A NOVEL TUMOR-SPECIFIC THERAPY FOR BREAST CANCER CELL-KILLING ACTIVITY OF CYTOSOLIC ERBB4

$45,304FY2008Department of the ArmyDOD

The Administrators Of Tulane Educational Fund

Investigators

A NOVEL TUMOR-SPECIFIC THERAPY FOR BREAST CANCER CELL-KILLING ACTIVITY OF CYTOSOLIC ERBB4 · GrantIndex